As congress prepares to vote on repeal of the Affordable Care Act, Drew Altman discusses whether Republican governors and congressional Republicans will be at odds over key issues when it comes to repealing and replacing the law in this Wall Street Journal Think Tank column.
- view as grid
- view as list
Larry Levitt’s January 2017 post explains the logistics of a “repeal and delay” approach to the Affordable Care Act, and outlines key elements of a proposed replacement plan from Rep. Tom Price, who is President Trump’s nominee for Secretary of Health and Human Services. The post is now available at The JAMA Forum.
In this Washington Post op-ed, Drew Altman discusses how Republicans’ ideas to change Medicaid and Medicare and repeal the Affordable Care Act would fundamentally change the federal role in health, calling it: the biggest change in health we are NOT debating.
In this April 2017 post, Larry Levitt discusses the current status of the Affordable Care Act’s health insurance marketplaces, and explains how the Trump administration’s choices — including whether to continue cost-sharing reduction payments to insurers — could influence stability of the marketplaces going forward. The post is now available at The JAMA Forum.
In this post for The JAMA Forum, the Kaiser Family Foundation’s Larry Levitt discusses the concept of allowing insurers to sell health plans across state lines and how such a proposal could affect people with pre-existing conditions.
In this guest column for VOX, the Kaiser Family Foundation’s Larry Levitt examines several key factors behind the expected premium rate increases for the Affordable Care Act’s marketplace plans in 2017 and what they mean for the stability of the marketplace.
This Drew Altman column in Axios reveals an uptick in the number of Americans with employer coverage, and discusses the implications for policy and politics.
Drew Altman analyzes health care messaging, concluding that its aimed mainly at activists in the base on both sides, and that the “The winning health care message will be about out of pocket costs,” in this Axios column.
In an Axios column, Drew Altman analyzes the political pros and cons of Medicare for All and Medicare buy-in plans for Democrats, and how they may handle it in Congress and the presidential campaign.
In an Axios column, Drew Altman uncovers a new pre-existing conditions problem – seniors on Medicare denied Medigap because they have pre-existing conditions – and discusses solutions.